In the ventral tegmental area, progestins' membrane-mediated actions for lordosis of hamsters and rats involve protein kinase A.
Sandra M Petralia, Alicia A Walf, Cheryl A Frye
Index: Neuroendocrinology 84(6) , 405-14, (2006)
Full Text: HTML
Abstract
Progestin-facilitated lordosis of hamsters and rats is enhanced by activation of dopamine type 1 (D1) or GABAA/benzodiazepine receptor complexes (GBRs) in the ventral tegmental area (VTA) and these effects involve G-proteins and second messengers, such as adenosine 3',5'-monophosphate (cAMP). We examined whether D1- and/or GBR-mediated increases in progestin-facilitated lordosis of female hamsters and rats involve the cAMP-dependent protein kinase, protein kinase A (PKA), in the VTA. In experiment 1, ovariectomized hamsters, primed with estradiol (E2; 10 microg at h 0) + progesterone (P; 100 microg at h 45), were first pre-tested for lordosis and motor behavior (h 48) and then infused with the PKA inhibitor, Rp-cAMP (100 ng/side), or vehicle. Thirty minutes later, hamsters were retested and then received infusions of the D1 agonist, SKF38393 (100 ng/side), the GBR agonist, muscimol (100 ng/side), or vehicle to the VTA. Hamsters were post-tested for lordosis and motor behavior 30 min later. In Experiment 2, ovariectomized rats, primed with E2 (10 microg at h 0), were first pre-tested for lordosis and then infused with Rp-cAMP (100 ng/side) or vehicle to the VTA at h 44. Immediately after testing, rats received infusions of SKF38393 (100 ng/side), muscimol (100 ng/side), or vehicle and were retested for lordosis. Rats were then infused with the neurosteroid, 5alpha-pregnan-3alpha-ol-20-one (3alpha,5alpha-THP; 100 or 200 ng/side), or beta-cyclodextrin vehicle and were post-tested for lordosis and motor behavior 10 and 60 min later. The enhancing effects of progestins or progestins plus D1 or GBR activation on lordosis of E2-primed hamsters and rats were blocked by the PKA inhibitor, Rp-cAMP. Thus, in the VTA, progestins' membrane actions involving D1 or GBRs are mediated, in part, by PKA.Copyright 2007 S. Karger AG, Basel.
Related Compounds
Related Articles:
2014-07-01
[Anal. Bioanal. Chem 406(18) , 4325-35, (2014)]
[Urinary tetrahydro-11-deoxycortisol].
2010-07-01
[Nihon Rinsho. 68 Suppl 7 , 401-3, (2010)]
A quantitative in vivo mouse model used to assay inhibitors of tumor-induced angiogenesis.
1991-02-15
[Cancer Res. 51(4) , 1339-44, (1991)]
Potent inhibitory effects of steroids in an in vitro model of angiogenesis.
1996-09-01
[J. Endocrinol. 150(3) , 457-64, (1996)]
Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients.
2006-01-01
[Clin. Endocrinol. (Oxf.) 64(1) , 37-45, (2006)]